- Issuer
- ADRhedged
- Inception Date
- Jan 6, 2025
- Region
- Europe (Europe Developed)
- Category
- Health & Biotech Equities
- Leveraged
- 1x (No leverage)
- Index Tracked
- GSK plc Local Shares Total Return
- Domicile
- United States
- Distribution Policy
- Distributing
- Asset Class
- Equity
- Asset Class Size
- Large-Cap
- Asset Class Style
- Value
- Assets Under Management
- $702K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
GSKH Performance Chart
GSK plc ADRhedged ETF (GSKH) is up 7.8% since the beginning of the year. GSKH is currently trading at $73 per share.
Loading charts...
Returns By Period
GSK plc ADRhedged ETF (GSKH) has returned 7.84% so far this year and 30.78% over the past 12 months.
GSK plc ADRhedged ETF
- 1D
- 1.34%
- 1M
- 4.57%
- YTD
- 7.84%
- 6M
- 8.19%
- 1Y
- 30.78%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -2.64%
- 1M
- 0.25%
- YTD
- 7.86%
- 6M
- 7.47%
- 1Y
- 24.32%
- 3Y*
- 19.90%
- 5Y*
- 11.79%
- 10Y*
- 13.33%
GSKH Monthly Returns History
Based on dividend-adjusted daily data since Jan 7, 2025, GSKH's average daily return is +0.13%, while the average monthly return is +2.37%. At this rate, an investment would double in approximately 2.5 years.
Historically, 72% of months were positive and 28% were negative. The best month was Feb 2026 with a return of +16.7%, while the worst month was Jun 2025 at -8.2%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 3 months.
On a daily basis, GSKH closed higher 52% of trading days. The best single day was Feb 5, 2025 with a return of +8.1%, while the worst single day was Oct 24, 2025 at -5.3%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 3.73% | 16.74% | -4.72% | -7.53% | -1.65% | 2.77% | 7.84% | ||||||
| 2025 | 3.71% | 6.32% | 0.43% | -0.23% | 3.00% | -8.22% | 0.44% | 5.42% | 9.28% | 10.60% | 2.08% | 0.46% | 37.05% |
Benchmark Metrics
GSK plc ADRhedged ETF has an annualized alpha of 32.60%, beta of 0.19, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since January 08, 2025.
- This ETF captured 42.96% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -164.10%) - a profile typical of hedging or uncorrelated assets.
- Beta of 0.19 may look defensive, but with R2 of 0.02 this ETF is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this ETF's risk.
- R2 of 0.02 means this ETF moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 32.60%
- Beta
- 0.19
- R²
- 0.02
- Upside Capture
- 42.96%
- Downside Capture
- -164.10%
Expense Ratio
GSKH has an expense ratio of 0.19%, which is considered low.
Return for Risk
Risk / Return Rank
GSKH ranks 36 for risk / return — below 36% of ETFs on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for GSK plc ADRhedged ETF (GSKH) and compare them to S&P 500 Index.
| GSKH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.83 | ||
| Sortino ratioReturn per unit of downside risk | -0.89 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 1.36 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 1.67 | 2.69 | -1.02 |
| Martin ratioReturn relative to average drawdown | 4.06 | 12.34 | -8.29 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Dividends
Dividend History
GSK plc ADRhedged ETF provided a 1.57% dividend yield over the last twelve months, with an annual payout of $1.15 per share.
| Period | TTM | 2025 |
|---|---|---|
| Dividend | $1.15 | $0.79 |
Dividend yield | 1.57% | 1.15% |
Monthly Dividends
The table displays the monthly dividend distributions for GSK plc ADRhedged ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.00 | $0.36 | $0.00 | $0.00 | $0.00 | $0.36 | ||||||
| 2025 | $0.79 | $0.79 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the GSK plc ADRhedged ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the GSK plc ADRhedged ETF was 18.54%, occurring on May 11, 2026. The portfolio has not yet recovered.
The current GSK plc ADRhedged ETF drawdown is 13.28%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 correction2026 | -18.54%May 2026 | 2mo 21d | — | 3mo 17dFeb 2026 - now |
2025 selloff2025 | -17.10%Apr 2025 | 1mo | 2mo 3d | 3mo 3dMar 2025 - Jun 2025 |
2025 correction2025 | -13.92%Jul 2025 | 1mo 8d | 2mo 11d | 3mo 19dJun 2025 - Sep 2025 |
2026 pullback2026 | -6.21%Jan 2026 | 5d | 13d | 18dJan 2026 - Feb 2026 |
2025 pullback2025 | -5.33%Oct 2025 | 0s | 5d | 5dOct 2025 - Oct 2025 |
Drawdown Indicators
| GSKH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -18.54% | -56.78% | +38.24% |
Max Drawdown (1Y)Largest decline over 1 year | -18.54% | -9.10% | -9.44% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -13.28% | -2.97% | -10.31% |
Average DrawdownAverage peak-to-trough decline | -5.65% | -10.72% | +5.07% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.61% | 1.97% | +5.64% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with GSKH
Add GSK plc ADRhedged ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with GSKH